10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0000914475-20-000018`
Period End Date	20200630
Filing Date	20200803
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	nbix-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 80 Cash Flow Statement 58 Stockholders Equity 30

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Amortized cost, current	`DebtSecuritiesAvailableForSaleAmortizedCostCurrent`	$530.30M	USD	Point-in-time
Amortized cost, current	`DebtSecuritiesAvailableForSaleAmortizedCostCurrent`	$557.30M	USD	Point-in-time
Amortized cost, noncurrent	`DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent`	$193.50M	USD	Point-in-time
Amortized cost, noncurrent	`DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent`	$299.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$112.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$415.10M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $530.3 million at June 30, 2020 and $557.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$533.20M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $530.3 million at June 30, 2020 and $557.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$558.20M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$126.60M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$148.40M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$17.30M	USD	Point-in-time
Inventories	`InventoryNet`	$22.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.50M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.60M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$831.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.15B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	93.20M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	92.30M	shares	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $193.5 million at June 30, 2020 and $299.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$195.20M	USD	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $193.5 million at June 30, 2020 and $299.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$299.70M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$72.10M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	93.20M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	92.30M	shares	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$74.30M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNiRestricted`	$50.70M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNiRestricted`	$55.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$41.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$44.60M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.20M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.20M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$3.60M	USD	Point-in-time
Total assets	`Assets`	$1.31B	USD	Point-in-time
Total assets	`Assets`	$1.52B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$137.10M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$141.30M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtCurrent`	$408.80M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtCurrent`	$419.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$15.20M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$573.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$565.30M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$84.30M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$86.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$17.10M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$27.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$669.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$684.40M	USD	Point-in-time
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding at June 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding at June 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220.0 shares authorized; issued and outstanding shares were 93.2 at June 30, 2020 and 92.3 at December 31, 2019	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, $0.001 par value; 220.0 shares authorized; issued and outstanding shares were 93.2 at June 30, 2020 and 92.3 at December 31, 2019	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.77B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.84B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.60M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.02B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.13B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$636.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$831.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$409.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$483.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$480.80M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$700.30M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.52B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.31B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$321.90M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$302.40M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$539.50M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$183.50M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.60M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$4.50M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.40M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.70M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$139.20M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$61.70M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$80.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$99.40M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$46.00M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$118.10M	USD	2 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$46.00M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$5.00M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$80.80M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$214.30M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$96.50M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$168.30M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$149.10M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$225.80M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$388.50M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$404.00M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$135.50M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-66.60M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$76.60M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$34.40M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.30M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.90M	USD	1 Quarter
Interest expense	`InterestExpense`	$16.50M	USD	2 Qtrs
Interest expense	`InterestExpense`	$15.80M	USD	2 Qtrs
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$21.00M	USD	1 Quarter
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$11.30M	USD	1 Quarter
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-5.20M	USD	2 Qtrs
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$22.70M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$8.30M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$9.20M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$3.60M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$4.60M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-13.40M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$17.70M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$16.10M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$6.60M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-50.50M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$122.10M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$52.10M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$83.20M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$800.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.10M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.60M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$300.00K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$117.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$51.30M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-50.80M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$79.60M	USD	1 Quarter
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$900.00K	USD	1 Quarter
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$6.00M	USD	1 Quarter
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.20M	USD	2 Qtrs
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.60M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$120.20M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$85.60M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$52.20M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-48.20M	USD	2 Qtrs
Net income (loss) per share, basic (in USD per share)	`EarningsPerShareBasic`	$-0.56	USD	2 Qtrs
Net income (loss) per share, basic (in USD per share)	`EarningsPerShareBasic`	$1.26	USD	2 Qtrs
Net income (loss) per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Net income (loss) per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.86	USD	1 Quarter
Net income (loss) per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$1.20	USD	2 Qtrs
Net income (loss) per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.54	USD	1 Quarter
Net income (loss) per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.56	USD	2 Qtrs
Net income (loss) per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.81	USD	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	91.20M	shares	2 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	93.00M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	91.40M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	92.80M	shares	2 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.60M	shares	2 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.20M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	94.80M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	91.20M	shares	2 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$117.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$51.30M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-50.80M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$79.60M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$33.70M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$52.30M	USD	2 Qtrs
Depreciation	`Depreciation`	$4.20M	USD	2 Qtrs
Depreciation	`Depreciation`	$3.40M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$10.00M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$9.30M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$700.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$700.00K	USD	2 Qtrs
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$21.00M	USD	1 Quarter
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$11.30M	USD	1 Quarter
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-5.20M	USD	2 Qtrs
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$22.70M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$700.00K	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-600.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.80M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$39.10M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$4.70M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.20M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-5.10M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.70M	USD	2 Qtrs
Other assets and liabilities, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-11.30M	USD	2 Qtrs
Other assets and liabilities, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$1.40M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-48.30M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$157.10M	USD	2 Qtrs
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$235.90M	USD	2 Qtrs
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$288.60M	USD	2 Qtrs
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$421.20M	USD	2 Qtrs
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$339.70M	USD	2 Qtrs
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	$54.70M	USD	2 Qtrs
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.40M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.00M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$40.70M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$126.60M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.10M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.90M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.10M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.90M	USD	2 Qtrs
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-700.00K	USD	2 Qtrs
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$302.80M	USD	2 Qtrs
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$418.30M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.20M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.50M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$146.50M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$418.30M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.20M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.50M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$146.50M	USD	Point-in-time
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$900.00K	USD	2 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$900.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.80M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.80M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$400.00K	USD	2 Qtrs

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$636.90M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$831.20M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$409.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$483.70M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$480.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$700.30M	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$117.00M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$51.30M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-50.80M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$79.60M	USD	1 Quarter
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$6.00M	USD	1 Quarter
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.60M	USD	2 Qtrs
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$900.00K	USD	1 Quarter
Unrealized gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.20M	USD	2 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$52.30M	USD	2 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.90M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$29.50M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$33.70M	USD	2 Qtrs
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.30M	USD	1 Quarter
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$15.80M	USD	1 Quarter
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$19.10M	USD	2 Qtrs
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.90M	USD	2 Qtrs
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.50M	USD	2 Qtrs
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.70M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$636.90M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$831.20M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$409.30M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$483.70M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$480.80M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$700.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.